Sauter, Daniel

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., Nakagawa, S., & Sato, K. (2020) · Cell Reports

SARS-CoV-2 and COVID-19 Researchinterferon and immune responses

Cited by 433

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

Nchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 146

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy Against Corona and Influenza Viruses

Lawrenz, J., Wettstein, L., Alfonso, A. R., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., et al. (2025) · Advanced Science

SARS-CoV-2 and COVID-19 ResearchProtease and Inhibitor Mechanisms

Cited by 8

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad‐Spectrum Efficacy against Corona and Influenza Viruses

Lawrenz, J., Wettstein, L., Rodríguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., et al. (2025) · Advanced Science

SARS-CoV-2 and COVID-19 ResearchProtease and Inhibitor Mechanisms

Cited by 8